Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells

J Cell Mol Med. 2016 Dec;20(12):2289-2298. doi: 10.1111/jcmm.12919. Epub 2016 Jul 15.

Abstract

Epithelial-mesenchymal transition (EMT) and renal fibrosis are closely involved in chronic kidney disease. Inhibition of histone deacetylase (HDAC) has an anti-fibrotic effect in various diseases. However, the pathophysiological role of isoform-specific HDACs or class-selective HDACs in renal fibrosis remains unknown. Here, we investigated EMT markers and extracellular matrix (ECM) proteins in a human proximal tubular cell line (HK-2) by using HDAC inhibitors or by knockdown of class I HDACs (HDAC1, 2, 3 and 8). Trichostatin A (TSA), MS275, PCI34051 and LMK235 inhibited ECM proteins such as collagen type I or fibronectin in transforming growth factor β1 (TGF-β1)-induced HK2 cells. However, restoration of TGF-β1-induced E-cadherin down-regulation was only seen in HK-2 cells treated with TSA or MS275, but not with PCI34051, whereas TGF-β1-induced N-cadherin expression was not affected by the inhibitors. ECM protein and EMT marker levels were prevented or restored by small interfering RNA transfection against HDAC8, but not against other class I HDACs (HDAC1, 2 and 3). E-cadherin regulation is mediated by HDAC8 expression, but not by HDAC8 enzyme activity. Thus, class I HDACs (HDAC1, 2, 3 and 8) play a major role in regulating ECM and EMT, whereas class IIa HDACs (HDAC4 and 5) are less effective.

Keywords: E-cadherin; HK-2 cells; class I HDAC; epithelial-mesenchymal transition (EMT); renal fibrosis.

MeSH terms

  • Antigens, CD
  • Benzamides / pharmacology
  • Biomarkers / metabolism
  • Cadherins / metabolism*
  • Cell Line
  • Down-Regulation / drug effects
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism*
  • Epithelial-Mesenchymal Transition / drug effects
  • Extracellular Matrix Proteins / metabolism
  • Gene Knockdown Techniques
  • Histone Deacetylase Inhibitors / pharmacology
  • Histone Deacetylases / metabolism*
  • Humans
  • Hydroxamic Acids / pharmacology
  • Indoles / pharmacology
  • Kidney Tubules, Proximal / cytology*
  • Pyridines / pharmacology
  • Transforming Growth Factor beta1 / pharmacology

Substances

  • Antigens, CD
  • Benzamides
  • Biomarkers
  • CDH1 protein, human
  • Cadherins
  • Extracellular Matrix Proteins
  • Histone Deacetylase Inhibitors
  • Hydroxamic Acids
  • Indoles
  • PCI 34051
  • Pyridines
  • Transforming Growth Factor beta1
  • entinostat
  • trichostatin A
  • Histone Deacetylases